HRT Financial’s Bluejay Diagnostics BJDX Stock Holding History

HRT Financial’s Portfolio BJDX Stock Details BJDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-198	Closed	-$5K	–	2452
2024 Q3	$5K	Buy	+198	New	+$14.2K	﹤0.01%	2265
2023 Q3	–	Sell	-1	Closed	-$8K	–	2416
2023 Q2	$8K	Buy	+1	New	+$9.04K	﹤0.01%	2185

Other funds holding BJDX

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HRT Financial's BJDX Position: Q4 2024 in Review

HRT Financial sold out of Bluejay Diagnostics (BJDX) in Q4 2024, closing a stake of 198 shares — an estimated $5K sold.

HRT Financial first reported a position in BJDX in Q2 2023 and held it in 2 quarters. The position peaked at $8K in Q2 2023. 3 funds tracked by Wall St. Rank hold BJDX as of Q4 2024.

HRT Financial reported no remaining Bluejay Diagnostics position as of Q4 2024 after selling out during the quarter.
HRT Financial sold 198 Bluejay Diagnostics shares in Q4 2024, an estimated $5K.
HRT Financial first reported a position in Bluejay Diagnostics in Q2 2023 and held it in 2 quarters.
HRT Financial's Bluejay Diagnostics position peaked at $8K in Q2 2023.
3 funds tracked by Wall St. Rank held Bluejay Diagnostics as of Q4 2024.

Based on HRT Financial's 13F filing for Q4 2024, filed 14 Feb 2025.